This wiki has undergone a migration to Confluence found Here
Difference between revisions of "ALLERGIES, ADVERSE REACTIONS OR ALERTS"
Jump to navigation
Jump to search
Bamarquard (talk | contribs) (Initial creation) |
Bamarquard (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | + | SDWG formed the CDA template example task force to collect and share member submitted samples. The task force developed a process with SDWG to receive approval for samples. | |
| + | |||
| + | The approved samples and development in progress are posted below. | ||
| + | |||
| + | Link to main page [http://wiki.hl7.org/index.php?title=CDA_Example_Task_Force CDA Example Task Force] | ||
| + | |||
| + | |||
| + | ==No Known Allergies with Author Timestamp== | ||
* Approved by: Task force on 1/9/2014. Approved by SDWG 1/16/2014. | * Approved by: Task force on 1/9/2014. Approved by SDWG 1/16/2014. | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 12: | Line 19: | ||
| − | + | ==No Known Medication Allergies with Author Timestamp== | |
* Approved by: Task force on 10/23/2014. Approved by SDWG 11/06/2014. | * Approved by: Task force on 10/23/2014. Approved by SDWG 11/06/2014. | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 25: | Line 32: | ||
| − | + | ==Allergy to specific substance (cat hair)== | |
* Approved by: Task force approved 4/10/2014. Withdrawn from consideration since not clinically relevant. | * Approved by: Task force approved 4/10/2014. Withdrawn from consideration since not clinically relevant. | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 38: | Line 45: | ||
| − | + | ==Allergy to Specific Drug== | |
* Approved by: Task force approved 4/10/2014. | * Approved by: Task force approved 4/10/2014. | ||
* CDA Implementation Guide where template(s) is(are) defined: [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] | * CDA Implementation Guide where template(s) is(are) defined: [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] | ||
| Line 53: | Line 60: | ||
| − | + | ==Allergy to Drug Class== | |
* Approved by: Task force approved 4/10/2014. | * Approved by: Task force approved 4/10/2014. | ||
* CDA Implementation Guide where template(s) is(are) defined: [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] | * CDA Implementation Guide where template(s) is(are) defined: [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] | ||
| Line 68: | Line 75: | ||
| − | + | ==Propensity to adverse reaction to substance (Latex)== | |
* Approved by: Task Force approved 4/17/2014 | * Approved by: Task Force approved 4/17/2014 | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 81: | Line 88: | ||
| − | + | ==Food allergy (Egg)== | |
* Approved by: Task Force approved 4/17/2014 | * Approved by: Task Force approved 4/17/2014 | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 94: | Line 101: | ||
| − | + | ==Drug intolerance with multiple reactions (epinephrine)== | |
* Approved by: Task Force approved 4/17/2014 | * Approved by: Task Force approved 4/17/2014 | ||
* [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | * [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
| Line 107: | Line 114: | ||
| − | + | ==Drug intolerance with multiple reactions (codeine)== | |
* Approved by: To be reviewed | * Approved by: To be reviewed | ||
** [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ** [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=258 C-CDA 1.1] Implementation Guide Example | ||
Latest revision as of 16:19, 7 January 2015
SDWG formed the CDA template example task force to collect and share member submitted samples. The task force developed a process with SDWG to receive approval for samples.
The approved samples and development in progress are posted below.
Link to main page CDA Example Task Force
Contents
- 1 No Known Allergies with Author Timestamp
- 2 No Known Medication Allergies with Author Timestamp
- 3 Allergy to specific substance (cat hair)
- 4 Allergy to Specific Drug
- 5 Allergy to Drug Class
- 6 Propensity to adverse reaction to substance (Latex)
- 7 Food allergy (Egg)
- 8 Drug intolerance with multiple reactions (epinephrine)
- 9 Drug intolerance with multiple reactions (codeine)
No Known Allergies with Author Timestamp
- Approved by: Task force on 1/9/2014. Approved by SDWG 1/16/2014.
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7)
- No Known Allergies with Author Timestamp(Github)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example
- Reference to full CDA sample: No Known Allergies in compliant MU2 Sample (via GitHub)
- Custodian: Brett Marquard, brett@riverrockassociates.com (GitHub: brettmarquard)
- Validation location: SITE Validator TOC Ambulatory
- Comments: This is an example of how an author can record a patient has no known allergies.
No Known Medication Allergies with Author Timestamp
- Approved by: Task force on 10/23/2014. Approved by SDWG 11/06/2014.
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7)
- No Known Medication Allergies with Author Timestamp(Github)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example
- Reference to full CDA sample: No Known Medication Allergies in compliant MU2 Sample (via GitHub)
- Custodian: Brett Marquard, brett@riverrockassociates.com (GitHub: brettmarquard)
- Validation location: SITE Validator TOC Ambulatory
- Comments: This is an example of how an author can record a patient has no known medication allergies.
Allergy to specific substance (cat hair)
- Approved by: Task force approved 4/10/2014. Withdrawn from consideration since not clinically relevant.
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Allergy to specific substance (cat hair)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of an allergy to a specific substance (cat hair) using UNII as terminology with information on both allergic reaction and reaction severity. See DSTU 219 for update regarding act/code
Allergy to Specific Drug
- Approved by: Task force approved 4/10/2014.
- CDA Implementation Guide where template(s) is(are) defined: C-CDA 1.1
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Allergy to specific drug (penicillin) C-CDA 1.1
- CDA Implementation Guide where template(s) is(are) defined: C-CDA 2.0]
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30.2) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7.2) Reaction Observation (2.16.840.1.113883.10.20.22.4.9.2) Severity Observation (2.16.840.1.113883.10.20.22.4.8.2)
- Allergy to specific drug (penicillin) C-CDA 1.1
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of an allergy to a specific drug (penicillin) using RxNorm as terminology with information on both allergic reaction and reaction severity. For drug allergies, this example illustrates a good practice of encoding the allergen at the ingredient level (penicillin) not administration level (10 mg tablet). See DSTU 219 for update regarding act/code
Allergy to Drug Class
- Approved by: Task force approved 4/10/2014.
- CDA Implementation Guide where template(s) is(are) defined: C-CDA 1.1
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Allergy to drug class (penicillins)
- CDA Implementation Guide where template(s) is(are) defined: C-CDA 2.0]
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30.2) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7.2) Reaction Observation (2.16.840.1.113883.10.20.22.4.9.2) Severity Observation (2.16.840.1.113883.10.20.22.4.8.2)
- Allergy to drug class (penicillins)
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of an allergy to a drug class (penicillins) using NDF-RT as terminology with information on both allergic reaction and reaction severity. See DSTU 219 for update regarding act/code
Propensity to adverse reaction to substance (Latex)
- Approved by: Task Force approved 4/17/2014
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Propensity to adverse reaction to substance (Latex)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of a propensity to substance allergy with information on both allergic reaction and reaction severity. It was based upon discussion with Russ Leftwich and Lisa Nelson in coordination with Patient Care Committee. See DSTU 219 for update regarding act/code
Food allergy (Egg)
- Approved by: Task Force approved 4/17/2014
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Food allergy (Egg)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of a food allergy with information on both allergic reaction and reaction severity. It was based upon discussion with Russ Leftwich and Lisa Nelson in coordination with Patient Care Committee. See DSTU 219 for update regarding act/code
Drug intolerance with multiple reactions (epinephrine)
- Approved by: Task Force approved 4/17/2014
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Drug intolerance with multiple reactions (epinephrine)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: Allergies in empty CCD
- Custodian: John D'Amore jdamore@diameterhealth.com (GitHub: jddamore)
- Validation location: TTT Validator
- Comments: This is an example of a propensity to drug adverse event with information on multiple allergic reactions each with reaction severity. It was based upon discussion with Russ Leftwich and Lisa Nelson in coordination with Patient Care Committee. See DSTU 219 for update regarding act/code
Drug intolerance with multiple reactions (codeine)
- Approved by: To be reviewed
- C-CDA 1.1 Implementation Guide Example
- TemplateId(s) illustrated: Allergy Concern Act (2.16.840.1.113883.10.20.22.4.30) and Allergy Intolerance Observation (2.16.840.1.113883.10.20.22.4.7) Reaction Observation (2.16.840.1.113883.10.20.22.4.9) Severity Observation (2.16.840.1.113883.10.20.22.4.8)
- Drug intolerance with multiple reactions (codeine)
- C-CDA 2.0 Example: none yet posted
- Known bad example?: Valid example with one error for act/code (based on DSTU 219 and C-CDA IG 2.0 clarification) and warning since severity only nested within reaction
- Reference to full CDA sample: https://github.com/LisaRNelson/LRN_HL7_CDA_Examples/blob/master/Allergy_Intolerance_Observation_Codeine.xml Allergies in empty CCD]
- Custodian: Lisa R. Nelson LisaRNelson@cox.net (GitHub: lisarnelson)
- Validation location: TTT Validator
- Comments: This is an example of a propensity to drug adverse event with information on multiple allergic reactions each with reaction severity. It was based upon discussion with Rob Hausam and John D'Amore and Russ Leftwich in coordination with Patient Care Committee. This sample replaces the Epinephrine sample which had less clinical accuracy/relevance. See DSTU 219 for update regarding act/code
